Author Question: A/An _____ system provides the means for tracking organizational resources, including people, ... (Read 67 times)

krzymel

  • Hero Member
  • *****
  • Posts: 548
A/An _____ system provides the means for tracking organizational resources, including people, processes, and technology.
 a. MRP
 b. ERP
 c. EDI
 d. legacy
 e. decision support

Question 2

A subsidiary of a company from the United States incorporated in any country of the European Union is:
 a. subject to foreign exchange restrictions
  b. forced to pay multiple tariffs
  c. exempt from U.S. taxation
  d. a corporate citizen of the European Union



Rilsmarie951

  • Sr. Member
  • ****
  • Posts: 316
Answer to Question 1

b

Answer to Question 2

D
A reason to form an EU subsidiary is to avoid exchange restrictions and multiple tariffs. Although subsidiaries may deduct taxes paid abroad, they are not exempt for U.S. taxation. The text states that, a subsidiary of a company from the United States incorporated in any country of the European Union is a corporate citizen of the European Union.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

Acetaminophen (Tylenol) in overdose can seriously damage the liver. It should never be taken by people who use alcohol heavily; it can result in severe liver damage and even a condition requiring a liver transplant.

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library